Inovalon signed a definitive agreement on 11 November 2026 to acquire DrFirst, a provider of e-prescribing and clinical workflow technology. Financial terms were not disclosed.
Why Inovalon is buying DrFirst
The companies say DrFirst's electronic prescribing, prior authorisation, benefit determination and patient communication capabilities will extend Inovalon's data and analytics platform, with the combined group expected to serve more than 2,000 hospitals and 240,000 prescribing providers.
Regulatory approvals and timing
The transaction is subject to regulatory approvals and customary closing conditions.
Market context
Inovalon is led by chief executive Adam Kansler and DrFirst by chief executive Laizer Kornwasser. Inovalon was taken private by a Nordic Capital-led consortium in 2021.






